Skip to main content
. 2020 Jul 25;57:166–170. doi: 10.1016/j.amsu.2020.07.040

Table 5.

Prevalence of steatosis in patients with NAFLD and with other liver etiology.

NAFLD n = 310 others
n = 269
P-value
No steatosis 131 (42.2%) 112 (41.6%) 0.04
Steatosis 179 (57.7%) 157 (58.4%) 0.03
 S1 16 (5.2%) 45 (16.7%) 0.00
 S2 22 (7.0%) 34 (12.6%) 0.00
 S3 141 (45.5%) 78 (28.9%) 0.04